Columbus McKinnon experienced sluggish volume growth in its fiscal fourth quarter, with guidance indicating only modest core growth in 2027 despite some improvement in short-cycle trends. While demand for automation products remains strong, the company faces risks from weaker manufacturing and warehouse construction spending, as well as cautious industrial capital expenditures. The company plans to focus on deleveraging for the coming years. Current valuations suggest skepticism about meeting margin and growth targets, but if mid-single-digit revenue growth and low-20% EBITDA margins are achieved, the stock could be undervalued. Investors will be watching for progress on margin improvements and synergy realization.
Cullinan Therapeutics presented initial Phase 1 clinical data for CLN-978, a CD19xCD3 T cell engager, showing clinical benefits including remissions in patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The drug demonstra...
L'Oréal continues to demonstrate strong fundamentals with double-digit growth in emerging markets and solid performance in North America and China. Despite a robust balance sheet supporting buybacks and dividends, the combined shareholder yield remai...
MSCI Inc. reported a 14.1% year-over-year revenue increase in Q1 2026, supported by strong recurring revenues and high client retention of 95.4%. The company benefits from accelerating ETF assets under management growth and operates with robust lever...
Alliance Resource Partners (ARLP) is considered a cautious buy due to its attractive 9%+ yield, reasonable valuation, and improving balance sheet metrics. The stock trades at a forward P/E of 11.87x, expected to drop to 8.5x by 2028, indicating poten...
Annaly Capital Management's preferred shares, especially NLY-G, are among the least risky in the mortgage REIT sector but currently trade at high valuations with an 8.22% yield and a negative yield to call. The low floating spread means dividend inco...
